Changchun BCHT Biotechnology Hits Day High with 5.67% Surge

Changchun BCHT Biotechnology Co. has experienced a notable increase of 5.67% on June 29, 2026, reaching an intraday high of CNY 14.35. This performance stands in contrast to the China Shanghai Composite, which rose by 1.16% on the same day. Despite this day's positive movement, the company's longer-term performance metrics reveal significant challenges. Over the past year, Changchun BCHT has seen a decline of 30.88%, and its year-to-date performance is down by 23.91%. The stock has also struggled over the last five years, with a staggering drop of 85.68%. Financial indicators show that the company has faced substantial difficulties, including a net sales decline of 53.5% reported in its latest quarterly results. Operating profit has also been severely impacted, with a five-year annual growth rate of -178.63%. The company's return on equity stands at -6.95%, reflecting ongoing financial strain. As a mid-cap player in the pharmaceuticals and biotechnology sector, Changchun BCHT's current market capitalization is CNY 6,060 million, and it maintains a dividend yield of 1.15%.